VETOQUINOL ACQUIRES THE RIGHTS FOR DRONTAL® AND PROFENDER® FAMILIES FROM ELANCO ANIMAL HEALTH FOR AUSTRALIA
January 11th, 2021 (Lure, France) - Vetoquinol announced today the acquisition of the Australian rights to Drontal® and Profender® product families from Elanco Animal Health.
- Public releases
INVESTORS CORNER
Vetoquinol has been listed on the Euronext Paris stock market since November 16th.
Consult the documents of the Meeting
Composition of the bodies of Corporate Management and Governance
Financial information and key figures: annual, half-year and by sector key figures